newsfilter
← Latest News
Business Wire·

Xeris Biopharma to Report Second Quarter 2025 Financial Results on August 7, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today